Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.19.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

Segment Reporting as of and for the year ended December 31, 2018

 

    Treatment     Services     Medical     Segments Total     Corporate (2)     Consolidated Total  
Revenue from external customers   $ 36,271     $ 13,268           $ 49,539 (3)   $     $ 49,539  
Intercompany revenues     509       70             579              
Gross profit     7,197       1,264             8,461             8,461  
Research and development     483             811       1,294       76       1,370  
Interest income                             295       295  
Interest expense     (22 )     (2 )           (24 )     (227 )     (251 )
Interest expense-financing fees                             (38 )     (38 )
Depreciation and amortization     943       465             1,408       47       1,455  
Segment income (loss) before income taxes     4,550 (6)     (756 )     (811 )     2,983       (4,993 )     (2,010 )
Income tax (benefit) expense     (943 )(7)                 (943 )     7       (936 )
Segment income (loss)     5,493       (756 )     (811 )     3,926       (5,000 )     (1,074 )
Segment assets(1)     32,800       5,188       25       38,013       19,429 (4)     57,442  
Expenditures for segment assets     1,311       117             1,428       4       1,432  
Total debt                             3,302 (5)     3,302  

 

Segment Reporting as of and for the year ended December 31, 2017

 

    Treatment     Services     Medical     Segments Total     Corporate (2)     Consolidated Total  
Revenue from external customers   $ 37,750     $ 12,019           $ 49,769 (3)   $     $ 49,769  
Intercompany revenues     362       31             393              
Gross profit     7,916       704             8,620             8,620  
Research and development     439             1,141       1,580       15       1,595  
Interest income                             140       140  
Interest expense     (35 )     (5 )           (40 )     (275 )     (315 )
Interest expense-financing fees                             (35 )     (35 )
Depreciation and amortization     3,228       536             3,764       39       3,803  
Segment income (loss) before income taxes     3,577 (8)     (2,286 )     (1,141 )     150       (4,973 )     (4,823 )
Income tax (benefit) expense     (1,290 )(7)                 (1,290 )     5       (1,285 )
Segment income (loss)     4,867       (2,286 )     (1,141 )     1,440       (4,978 )     (3,538 )
Segment assets(1)     32,724       6,324       548       39,596       19,942 (4)     59,538  
Expenditures for segment assets     396       43             439             439  
Total debt                             3,847 (5)     3,847  

 

  (1) Segment assets have been adjusted for intercompany accounts to reflect actual assets for each segment.
     
  (2) Amounts reflect the activity for corporate headquarters not included in the segment information.

 

  (3) The Company performed services relating to waste generated by the domestic government clients (includes U.S federal, state and local), either directly as a prime contractor or indirectly for others as a subcontractor to government entities, representing approximately $34,811,000 or 70.3% of total revenue for 2018 and $37,019,000 or 74.4% of total revenue for 2017. The following reflects such revenue generated by our two segments:

 

    2018     2017  
Treatment   $ 25,181,000     $ 27,956,000  
Services     9,630,000       9,063,000  
Total   $ 34,811,000     $ 37,019,000  

 

  (4) Amount includes assets from our discontinued operations of $306,000 and $365,000 at December 31, 2018 and 2017, respectively.
     
  (5) Net of debt issuance costs of ($80,000) and ($115,000) for 2018 and 2017, respectively (see “Note 10 – “Long-Term Debt” for additional information).
     
  (6) Amount includes a net gain of $1,596,000 recorded resulting from the exchange offer of the Series B Preferred Stock of the Company’s M&EC subsidiary (see “Note 8 – Series B Preferred Stock”)
     
  (7) For the year ended December 31, 2018 and 2017, amount includes a tax benefit recorded in the amount of approximately $1,235,000 and $1,695,000, respectively, resulting from the TCJA enacted on December 22, 2017 (see “Note 14 – Income Taxes” for further information of this tax benefit).
     
  (8) Amount includes tangible asset impairment loss of $672,000 recorded in connection with the closure of M&EC (see “Note 4 – M&EC Facility”).

Schedule of Revenue by Major Customers by Reporting Segments

    2018     2017  
Treatment   $ 25,181,000     $ 27,956,000  
Services     9,630,000       9,063,000  
Total   $ 34,811,000     $ 37,019,000